Диссертация (1173252), страница 18
Текст из файла (страница 18)
Furtner, V. Scho¨pf, K. Schewzow et al. // AJNR Am J Neuroradiol. – 2014. – Vol.35. – P. 482– 89.42.Garcia, D. M. Pseudo-continuous flow driven adiabatic inversion forarterial spin labeling / D. M. Garcia, C. De Bazelaire, D. Alsop // Proc Int Soc MagnReson Med. – 2005. – Vol. 13. – P. 37-50.43.Golay, X. Perfusion imaging using arterial spin labeling / X. Golay, J.Hendrikse, T. C. Lim // Top Magn Reson Imaging. – 2004. – Vol.
15. – P. 10-27.11644.Golay, X. Arterial spin labeling: benefits and pitfalls of high magnetic field/ X. Golay, E. T. Petersen // Neuroimaging Clin N Am. – 2006. – Vol. 16. – P. 259-268.45.Harris, A. D. Diffusion and perfusion MR imaging of acute ischemic stroke/ A. D. Harris, S. B. Coutts, R. Frayne // Magn Reson Imaging Clin N Am. – 2009.
–Vol. 17. – P. 291-313.46.Hefti, M. Susceptibility to 5-aminolevulinic acid based photodynamictherapy in WHO I meningioma cells corresponds to ferrochelatase activity / M. Hefti, F.Holenstein, I. Albert rt al. // Photochem Photobiol. – 2011. – Vol. 87(1). – P. 235-41.47.Hendrikse, J. Internal carotid artery occlusion assessed at pulsed arterialspin-labeling perfusion MR imaging at multiple delay times / J. Hendrikse, M. J. vanOsch, D.
R. Rutgers et al. // Radiology. – 2004. – Vol. 233. – P. 899-904.48.Hernandez-Garcia, L. Quantification of perfusion fMRI using a numericalmodel of arterial spin labeling that accounts for dynamic transit time effects / L.Hernandez-Garcia, G. R. Lee, A. L. Vazquez et al. // Magn Reson Med. – 2005. – Vol.54. – P. 955-964.49.Hirai, T. Quantitative Blood Flow Measurements in Gliomas UsingArterial Spin-Labeling at 3T: Intermodality Agreement and Inter- and IntraobserverReproducibility Study / T. Hirai, M. Kitajima, H.
Nakamura et al. // AJNR Am JNeuroradiol. – 2011. – Vol. 32. – P. 2073-79.50.Jaros, E. Prognostic implications of p53 protein, epidermal growth factorreceptor and Ki-67 labelling in brain tumours / E. Jaros, R. Perry, L. Adam et al. // Br JCancer. – 1992. – Vol. 66(2). – P. 373-385.51.Jiang, J. Comparative analysis of arterial spin labeling and dynamicsusceptibility contrast perfusion imaging for quantitative perfusion measurements ofbrain tumors / J.
Jiang, L. Zhao, Y. Zhang et al. // Int J Clin Exp Pathol. – 2014. – Vol.7(6). – P. 2790-99.52.Jin, G. Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarateproduction in IDH1-mutated gliomas / G. Jin, Z. J. Reitman, C. G. Duncan et al. //Cancer Res. – 2013. – Vol.
73(2). – P. 496–501.11753.Johnson, N. A. Pattern of cerebral hypoperfusion in Alzheimer disease andmild cognitive impairment measured with arterial spin-labeling MR imaging: initialexperience / N. A. Johnson, G. H. Jahng, M. W. Weiner et al. – Radiology. – 2005. –Vol.
234. – P. 851-859.54.Juratli, T. A. Accumulation of 2-hydroxyglutarate is not a biomarker formalignant progression in IDH-mutated low-grade gliomas / T. A. Juratli, M. Peitzsch,K. Geiger et al. // Neuro Oncol. – 2013. – Vol. 15(6). – P. 682–690.55.Karamitopoulou, E. Ki-67 immunoreactivity in human central nervoussystem tumors: a study with MIB 1 monoclonal antibody on archival material / E.Karamitopoulou, E. Perentes, I. Diamantis et al.
Acta Neuropathol. – 1994. – Vol. 87. –P. 47-54.56.Kim, H. S. A prospective study on the added value of pulsed arterial spin-labeling and apparent diffusion coefficients in the grading of gliomas / H. S. Kim, S. Y.Kim // AJNR Am J Neuroradiol. – 2007. – Vol. 28. – P. 1693–99.57.Kim, M. J. Diagnostic accuracy and interobserver variability of pulsedarterial spin labeling for glioma grading / M. J. Kim, H. S. Kim, J. H. Kim et al.
// ActaRadiol. – 2008. – Vol. 9. – P. 450–57.58.Kim, S. G. Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functionalmapping / S. G. Kim // Magn Reson Med. – 1995. – Vol. 34. – P. 293-301.59.Knopp, E.
A. Glial neoplasms: dynamic contrast-enhanced T2*-weightedMR imaging / E. A. Knopp, S. Cha, G. Johnson et al. // Radiology. – 1999. – Vol. 211.– P. 791–98.60.Kwong, K. K. MR perfusion studies with T1-weighted echo planar imaging/ K. K. Kwong, D. A. Chesler, R.
M. Weisskoff et al. // Magn Reson Med. – 1995. –Vol. 34. – P. 878-887.61.Lacerda, S. Magnetic resonance perfusion and permeability imaging inbrain tumors / S. Lacerda, M. Law // Neuroimaging Clin N Am. – 2009. – Vol. 19. – P.527-557.11862.Law, M. Comparison of cerebral blood volume and vascular permeabilityfrom dynamic susceptibility contrast enhanced perfusion MR imaging with gliomagrade / M. Law, S. Yang, J.
S. Babb et al. // AJNR Am J Neuroradiol. – 2004. – Vol.25. – P. 746–55.63.Law, M. Gliomas: predicting time to progression or survival with cerebralblood volume measurements at dynamic susceptibility-weighted contrast-enhancedperfusion MR imaging / M. Law, R. J. Young, J. S. Babb et al. // Radiology. – 2008. –Vol.
247. – P. 490–98.64.Lin, Y. Comparison of Intravoxel Incoherent Motion Diffusion-WeightedMR Imaging and Arterial Spin Labeling MR Imaging in Gliomas / Y. Lin, J. Li, Z.Zhang et al. // BioMed Research International. – 2015. – Article ID 234245. – 10 p.65.Liu, H. L. Perfusion-weighted imaging of interictal hypoperfusion intemporal lobe epilepsy using FAIR-HASTE: comparison with H(2)(15)O PETmeasurements / H. L. Liu, P.
Kochunov, J. Hou et al. Magn Reson Med. – 2001. – Vol.45. – P. 431-435.66.Liu, T. Noninvasively evaluating the grading and IDH1 mutation status ofdiffuse gliomas by three-dimensional pseudo-continuous arterial spin labeling anddiffusion-weighted imaging / T. Liu, G. Cheng, X. Kang et al. // Neuroradiology. –2018.
– Vol. 60(7). – P. 693-702.67.Liu, T. T. Measurement of cerebral perfusion with arterial spin labeling:Part 1. Methods / T. T. Liu, G. G. Brown // J Int Neuropsychol Soc. – 2007. – Vol. 13. –P. 517-525.68.Louis, D. The 2016 World Health Organization Classification of Tumors ofthe Central Nervous System: a summary / D. Louis, A. Perry, G.
Reifenberger et al. //Acta Neuropathol. – 2016. – Vol. 131. – P. 803-820.69.Ma, H. Three-dimensional arterial spin labeling imaging and dynamicsusceptibility contrast perfusion-weighted imaging value in diagnosing glioma gradeprior to surgery / H. Ma, Z. Wang, X. Kai et al. Experimental and therapeutic medicine.– 2017. – Vol. 13. – P. 2691-98.11970.MacIntosh, B. J. Assessment of arterial arrival times derived from multipleinversion time pulsed arterial spin labeling MRI / B. J. MacIntosh, N. Filippini, M. A.Chappell et al.
Magn Reson Med. – 2010. – Vol. 63. – P. 641-647.71.Mardis, E. R. Recurring mutations found by sequencing an acute myeloidleukemia genome / E. R. Mardis, L. Ding, D. J. Dooling et al. N Engl J Med. – 2009. –Vol. 361(11). – P. 1058–1066.72.Mayer, A. Differential expression of HIF-1 in glioblastoma multiforme andanaplastic astrocytoma / A. Mayer, F. Schneider, P. Vaupel et al. // Int J Oncol. – 2012.– Vol. 41. – P. 1260–70.73.Molenaar, R. J. The driver and passenger effects of isocitratedehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation / R.
J.Molenaar, T. Radivoyevitch, J. P. Maciejewski et al. // Biochim Biophys Acta. – 2014.– Vol. 1846(2). – P. 326–341.74.Mullen, A. R. Genetically-defined metabolic reprogramming in cancer / A.R. Mullen, R. J. DeBerardinis // Trends Endocrinol Metab. – 2012a. – Vol. 23(11). – P.552–559.75.Nguyen, T. B. Comparison of the diagnostic accuracy of DSC- anddynamic contrast-enhanced MRI in the preoperative grading of astrocytomas / T. B.Nguyen, G. O. Cron, K.
Perdrizet et al. // AJNR Am J Neuroradiol. – 2015. – Vol. 36. –P. 2017–22.76.Ozsunar, Y. Glioma recurrence versus radiation necrosis? A pilotcomparison of arterial spin labeled, dynamic susceptibility contrast enhanced MRI, andFDG-PET imaging / Y. Ozsunar, M.
E. Mullins, K. Kwong et al. // Acad Radiol . –2010. – Vol. 17. – P. 282-290.77.Paiva, F. F. Measurement of cerebral perfusion territories using arterialspin labelling / F. F. Paiva, A. Tannús, A. C. Silva // NMR Biomed. – 2007. – Vol. 20. –P. 633-642.12078.Parsons, D. W. An integrated genomic analysis of human glioblastomamultiforme / D. W. Parsons, S. Jones, X. Zhang et al. // Science.
– 2008. – Vol. 321. –P. 1807–1812.79.Petersen, E. T. Model-free arterial spin labeling quantification approach forperfusion MRI / E. T. Petersen, T. Lim, X. Golay // Magn Reson Med. – 2006. – Vol.55. – P. 219-232.80.Petersen, E. T. Non-invasive measurement of perfusion: a critical review ofarterial spin labelling techniques / E.
T. Petersen, I. Zimine, Y. C. Ho et al. Br J Radiol.– 2006. – Vol. 79. – P. 688-701.81.Pollock, J. M. Arterial spin-labeled MR perfusion imaging: clinicalapplications / J. M. Pollock, H. Tan, R. A. Kraft et al. Magn Reson Imaging Clin N Am.– 2009. – Vol. 17. – P. 315-338.82.Potapov, A. A. First experience in 5-ALA fluorescence-guided andendoscopically assisted microsurgery of brain tumors / A. A. Potapov, D. J. Usachev, V.A.
Loshakov et al. // Med Las Applic. – 2008. – Vol. 23(4). – P. 202-208.83.Qiao, X. J. Arterial spin-labeling perfusion MRI stratifies progression-freesurvival and correlates with epidermal growth factor receptor status in glioblastoma / X.J. Qiao, B. M. Ellingson, H.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
